UPDATE: Synergy Pharma (SGYP) Higher on Linzess Approval (IRWD) (FRX)
Tweet
Share
E-mailGet Alerts FRX Hot Sheet
Join SI Premium – FREE
(Updated - August 30, 2012 11:36 AM EDT)
Synergy Pharmaceuticals (Nasdaq: SGYP) is moving higher following FDA approval for Linzess for Ironwood (Nasdaq: IRWD) and Forest Labs (NYSE: FRX). Shares are up 3 percent on the session.
Synergy Pharmaceuticals (Nasdaq: SGYP) is moving higher following FDA approval for Linzess for Ironwood (Nasdaq: IRWD) and Forest Labs (NYSE: FRX). Shares are up 3 percent on the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI Corp. (UGI) halted on volatility, up 6%
- U.S. Treasury doubles buyback operation size for long-dated bonds
- SEC proposes rules to create regime for some crypto contracts
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
